ETFs › GNOM

Global X Genomics & Biotechnology ETF (GNOM)

healthcare biotechnology genomics

GNOM offers focused exposure to companies involved in genomic science. It includes firms working on gene editing, genomic sequencing, and computational genomics. This ETF provides a way to invest in a potentially transformative field of medical research and development.

Key Info

AUM $180M
Expense Ratio 0.50%
Inception Date April 5, 2019
Distribution Frequency Annually
Weighting Method Modified Market Cap
Number of Holdings 40
Tracking Index Solactive Genomics Index

See Also

ARKG XBI IDNA

Last updated: September 7, 2024